AI system to detect and describe small-bowel mucosal damage in celiac and other enteropathies
Official title: Development and Validation of an Artificial Intelligence System for Detection and Characterization of Small Bowel Mucosal Atrophy in Celiac Disease and Non-Celiac Enteropathies: A Multicenter Observational Study
Run by Istituti Clinici Scientifici Maugeri SpA · NCT07387185 · Data updated 2026-11-12
This project will test if an artificial intelligence system can find and describe small-bowel mucosal atrophy and other lesions in adults having small-bowel endoscopy or capsule endoscopy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 380 (estimated) |
| Sponsor | Istituti Clinici Scientifici Maugeri SpA Academic / other |
| Locations | 1 site (Pavia, PV) |
| Status | Recruiting |
| Started | February 20, 2025 |
| Main results expected | March 1, 2028 |
| Study ends | March 1, 2028 |
| Registry record updated | February 4, 2026 |
| Trial ID | NCT07387185 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 and older who are undergoing small-bowel endoscopy or capsule endoscopy for suspected celiac disease or other enteropathies and who can give informed consent are ideal candidates.
✕Probably not a fit
Children under 18, patients who do not undergo endoscopic imaging or cannot provide informed consent, and cases where diagnosis depends solely on non-endoscopic tests are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter observational project will develop a deep-learning AI using anonymized retrospective endoscopy images and videos, then prospectively validate its performance on recorded procedures. In the retrospective phase, algorithms are trained to recognize mucosal atrophy and other lesions such as angiodysplasia, ulcers, and polyps. In the prospective phase, adult patients undergoing small-bowel endoscopy or capsule endoscopy will have their recorded videos analyzed offline by the AI and compared to standard human interpretation and biopsy results where available. The aim is to reduce missed lesions and decrease inter-observer variability in endoscopic characterization.
Why it matters
Potential benefit: If successful, the AI could help endoscopists detect and characterize small-bowel lesions more reliably, reducing missed diagnoses and improving diagnostic confidence.
How similar studies have gone: AI and deep-learning tools have shown promise in detecting gastrointestinal lesions and capsule endoscopy abnormalities, but application specifically for celiac-related mucosal atrophy is relatively novel and still being validated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (age ≥18 years). * Patients undergoing endoscopic investigation of the small bowel (endoscopy or capsule endoscopy) Exclusion Criteria: * Inability to provide informed consent.
Where it's running
-
ICS Maugeri IRCCS
Pavia, Pv, Italy Recruiting
Study contacts
- Study coordinator: Federico Biagi, MD
- Email: federico.biagi@icsmaugeri.it
- Phone: 0382592695
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mediterranean diet and processed food in adults with celiac disease on a gluten-free diet
This observational study looks at whether following a Mediterranean-style diet or eating more highly processed foods affects GI symptoms and quality of life in adults with celiac disease who have been on a strict gluten-free diet.
-
Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease
This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.
-
Nutrition and physical activity education for children with celiac disease
This study tests whether a combined nutrition and physical activity education program helps 8- to 12-year-olds with celiac disease improve body health, eating habits, activity, and quality of life while on a gluten-free diet.
-
Liver Fat and Scarring in People Suspected of Non-Celiac Wheat Sensitivity
This study looks to see if people with non-celiac wheat sensitivity have liver fat or fibrosis and how this relates to IBS/FD and celiac disease.
-
Omega-3 fats to reduce inflammation in adults with newly diagnosed celiac disease
This study tests whether adding omega-3 fatty acid supplements to a gluten-free plan helps reduce inflammation and promote intestinal healing in adults who have just been diagnosed with celiac disease.
-
Wheat sensitivity or IBS/functional dyspepsia in relatives of people with celiac disease
This project will test whether adults related to celiac patients have higher rates of non-celiac wheat sensitivity or IBS/functional dyspepsia and whether symptoms change on a wheat-free diet.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.